135 related articles for article (PubMed ID: 17312995)
41. Arsenic-induced apoptosis in malignant cells in vitro.
Akao Y; Yamada H; Nakagawa Y
Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769
[TBL] [Abstract][Full Text] [Related]
42. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells.
Cui X; Wakai T; Shirai Y; Yokoyama N; Hatakeyama K; Hirano S
Hum Pathol; 2006 Mar; 37(3):298-311. PubMed ID: 16613325
[TBL] [Abstract][Full Text] [Related]
43. Bcl-2 antisense oligodeoxynucleotide increases the sensitivity of leukemic cells to arsenic trioxide.
Zhang Y; Shen WL
Cell Biol Int; 2003; 27(12):953-8. PubMed ID: 14642526
[TBL] [Abstract][Full Text] [Related]
44. Metabolism of arsenic trioxide in acute promyelocytic leukemia cells.
Khaleghian A; Ghaffari SH; Ahmadian S; Alimoghaddam K; Ghavamzadeh A
J Cell Biochem; 2014 Oct; 115(10):1729-39. PubMed ID: 24819152
[TBL] [Abstract][Full Text] [Related]
45. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.
Lin TH; Kuo HC; Chou FP; Lu FJ
BMC Cancer; 2008 Feb; 8():58. PubMed ID: 18294404
[TBL] [Abstract][Full Text] [Related]
46. [In vitro study on arsenic trioxide-induced apoptosis of retinoic acid resistant acute promyelocytic leukemia cell line(MR-2)].
Cai X; Jia P; Shi X
Zhonghua Xue Ye Xue Za Zhi; 1998 Jul; 19(7):339-41. PubMed ID: 11189513
[TBL] [Abstract][Full Text] [Related]
47. Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias.
Tabellini G; Tazzari PL; Bortul R; Evangelisti C; Billi AM; Grafone T; Martinelli G; Baccarani M; Martelli AM
Br J Haematol; 2005 Sep; 130(5):716-25. PubMed ID: 16115127
[TBL] [Abstract][Full Text] [Related]
48. [Effects of all-trans retinoic acid, arsenic trioxide and daunorubicin on tissue factor expression in NB4 cells].
Guo W; Zhu J; Wang H
Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):453-5. PubMed ID: 11721405
[TBL] [Abstract][Full Text] [Related]
49. [Regulation of all-trans retinoic acid and arsenic trioxide on CD44v6 expression in NB4 cells].
Huang HF; Chen P; Lu R; Lin ZX; Wu Y; Chen YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):33-7. PubMed ID: 22391160
[TBL] [Abstract][Full Text] [Related]
50. Arsenic trioxide: acute promyelocytic leukemia and beyond.
Bachleitner-Hofmann T; Kees M; Gisslinger H
Leuk Lymphoma; 2002 Aug; 43(8):1535-40. PubMed ID: 12400595
[TBL] [Abstract][Full Text] [Related]
51. Catalase activity and arsenic sensitivity in acute leukemia.
Coe E; Schimmer AD
Leuk Lymphoma; 2008 Oct; 49(10):1976-81. PubMed ID: 18949620
[TBL] [Abstract][Full Text] [Related]
52. [In vitro study on arsenic trioxide-inducing apoptosis in primary acute promyelocytic leukemie cells].
Tang W; Chen G; Shen Z; Chen L; Shi X; Jia P; Shi G; Ni J; Chen S; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 1997 Dec; 18(12):623-6. PubMed ID: 15625759
[TBL] [Abstract][Full Text] [Related]
53. Arsenic trioxide promotes mitochondrial DNA mutation and cell apoptosis in primary APL cells and NB4 cell line.
Meng R; Zhou J; Sui M; Li Z; Feng G; Yang B
Sci China Life Sci; 2010 Jan; 53(1):87-93. PubMed ID: 20596959
[TBL] [Abstract][Full Text] [Related]
54. Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation.
Yuksel S; Saydam G; Uslu R; Sanli UA; Terzioglu E; Buyukececi F; Omay SB
Leuk Res; 2002 Apr; 26(4):391-8. PubMed ID: 11839383
[TBL] [Abstract][Full Text] [Related]
55. Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment.
Yedjou CG; Moore P; Tchounwou PB
Int J Environ Res Public Health; 2006 Jun; 3(2):136-40. PubMed ID: 16823087
[TBL] [Abstract][Full Text] [Related]
56. Arsenic trioxide: safety issues and their management.
Au WY; Kwong YL
Acta Pharmacol Sin; 2008 Mar; 29(3):296-304. PubMed ID: 18298894
[TBL] [Abstract][Full Text] [Related]
57. [Apoptosis of MR2 cells induced by Tanshinone II A combined with arsenic trioxide].
Li L; Zhang ZH; Zhao WD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):812-6. PubMed ID: 19950589
[TBL] [Abstract][Full Text] [Related]
58. [Regulation of arsenic trioxide-inducing apoptosis].
Huang X
Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):258-60. PubMed ID: 11601217
[TBL] [Abstract][Full Text] [Related]
59. [Experimental research on the effect of arsenic trioxide on the growth of prostate cancer PC-3 cell lines].
Jiang T; Jiang H; Wang Y
Zhonghua Nan Ke Xue; 2004 Aug; 10(8):578-81. PubMed ID: 15362517
[TBL] [Abstract][Full Text] [Related]
60. In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia.
La Rosée P; Johnson K; O'Dwyer ME; Druker BJ
Exp Hematol; 2002 Jul; 30(7):729-37. PubMed ID: 12135670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
